APA (7th ed.) Citation

Ko, B., Chang, M., Chiou, T., Chang, T., Chen, Y., Lin, S., . . . Chen, W. (2015). Different Adverse Event Profiles and Significant Hematological Improvement Are Noted When Deferasirox Was Used in Adult Patients with Chronic Transfusion-Related Iron Overload in Taiwan: Results from a Prospective Observational Clinical Trial. Blood, 126(23), 4554. https://doi.org/10.1182/blood.V126.23.4554.4554

Chicago Style (17th ed.) Citation

Ko, Bor-Sheng, et al. "Different Adverse Event Profiles and Significant Hematological Improvement Are Noted When Deferasirox Was Used in Adult Patients with Chronic Transfusion-Related Iron Overload in Taiwan: Results from a Prospective Observational Clinical Trial." Blood 126, no. 23 (2015): 4554. https://doi.org/10.1182/blood.V126.23.4554.4554.

MLA (9th ed.) Citation

Ko, Bor-Sheng, et al. "Different Adverse Event Profiles and Significant Hematological Improvement Are Noted When Deferasirox Was Used in Adult Patients with Chronic Transfusion-Related Iron Overload in Taiwan: Results from a Prospective Observational Clinical Trial." Blood, vol. 126, no. 23, 2015, p. 4554, https://doi.org/10.1182/blood.V126.23.4554.4554.